These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 2210989

  • 1. Generation of complement-derived anaphylatoxins in normal human donor corneas.
    Mondino BJ, Sumner HL.
    Invest Ophthalmol Vis Sci; 1990 Oct; 31(10):1945-9. PubMed ID: 2210989
    [Abstract] [Full Text] [Related]

  • 2. Complement-derived anaphylatoxins in human donor corneas treated with excimer laser.
    Gardner BP, Pleyer U, Mondino BJ, Sumner HL, Frieberg ML, Imperia PS.
    Ophthalmic Surg Lasers; 1995 Oct; 26(6):568-71. PubMed ID: 8746579
    [Abstract] [Full Text] [Related]

  • 3. Generation of complement membrane attack complex in normal human corneas.
    Mondino BJ, Chou HJ, Sumner HL.
    Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1576-81. PubMed ID: 8675400
    [Abstract] [Full Text] [Related]

  • 4. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
    Langone JJ, Das C, Bennett D, Terman DS.
    J Immunol; 1984 Aug; 133(2):1057-63. PubMed ID: 6610702
    [Abstract] [Full Text] [Related]

  • 5. Anaphylatoxin levels in human aqueous humor.
    Mondino BJ, Sumner H.
    Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1288-92. PubMed ID: 3488296
    [Abstract] [Full Text] [Related]

  • 6. [Atopic dermatitis. II. The status of complement proteins and the pathogenetic role of anaphylatoxins C4a, C3a and C5a].
    Sergeev IuV, Reznikov IuP, Lobanova EV, Pimenova NS.
    Vestn Dermatol Venerol; 1989 Aug; (4):4-7. PubMed ID: 2788339
    [Abstract] [Full Text] [Related]

  • 7. Anaphylatoxin levels in human vitreous humor.
    Mondino BJ, Sidikaro Y, Sumner H.
    Invest Ophthalmol Vis Sci; 1988 Jul; 29(7):1195-8. PubMed ID: 3262096
    [Abstract] [Full Text] [Related]

  • 8. Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a).
    Schifferli JA, Steiger G, Paccaud JP.
    Clin Exp Immunol; 1986 May; 64(2):407-14. PubMed ID: 3488858
    [Abstract] [Full Text] [Related]

  • 9. Inflammatory mediators in the vitreous humor of AIDS patients with retinitis.
    Mondino BJ, Sidikaro Y, Mayer FJ, Sumner HL.
    Invest Ophthalmol Vis Sci; 1990 May; 31(5):798-804. PubMed ID: 2110558
    [Abstract] [Full Text] [Related]

  • 10. Pulmonary injury induced by C3a and C5a anaphylatoxins.
    Stimler NP, Hugli TE, Bloor CM.
    Am J Pathol; 1980 Aug; 100(2):327-48. PubMed ID: 6967702
    [Abstract] [Full Text] [Related]

  • 11. The extracellular neutral cysteine proteinase of Entamoeba histolytica degrades anaphylatoxins C3a and C5a.
    Reed SL, Ember JA, Herdman DS, DiScipio RG, Hugli TE, Gigli I.
    J Immunol; 1995 Jul 01; 155(1):266-74. PubMed ID: 7602103
    [Abstract] [Full Text] [Related]

  • 12. [Complement activation and inflammation].
    Abe M.
    Rinsho Byori; 2006 Jul 01; 54(7):744-56. PubMed ID: 16913666
    [Abstract] [Full Text] [Related]

  • 13. Interleukin-1 upregulates anaphylatoxin receptors on mononuclear cells.
    Takabayashi T, Shimizu S, Clark BD, Beinborn M, Burke JF, Gelfand JA.
    Surgery; 2004 May 01; 135(5):544-54. PubMed ID: 15118592
    [Abstract] [Full Text] [Related]

  • 14. [A study on complement activation in cardiopulmonary bypass--experimental and clinical evaluations].
    Yamasaki M.
    Nihon Kyobu Geka Gakkai Zasshi; 1989 Feb 01; 37(2):234-41. PubMed ID: 2788676
    [Abstract] [Full Text] [Related]

  • 15. Study of complement-mediated anaphylaxis in humans. The role of IgG subclasses (IgG1 and/or IgG4) in the complement-activating capacity of immune complexes.
    Bergamaschini L, Santangelo T, Faricciotti A, Ciavarella N, Mannucci PM, Agostoni A.
    J Immunol; 1996 Feb 01; 156(3):1256-61. PubMed ID: 8558005
    [Abstract] [Full Text] [Related]

  • 16. Accumulation of anaphylatoxins and terminal complement complexes in inflammatory fluids.
    Bengtsson A, Bengtson JP, Rydenhag A, Roxvall L, Heideman M.
    J Intern Med; 1990 Aug 01; 228(2):173-6. PubMed ID: 2394968
    [Abstract] [Full Text] [Related]

  • 17. The anaphylatoxins bridge innate and adaptive immune responses in allergic asthma.
    Hawlisch H, Wills-Karp M, Karp CL, Köhl J.
    Mol Immunol; 2004 Jun 01; 41(2-3):123-31. PubMed ID: 15159057
    [Abstract] [Full Text] [Related]

  • 18. Early plasma complement C3a levels correlate with functional outcome after aneurysmal subarachnoid hemorrhage.
    Mack WJ, Ducruet AF, Hickman ZL, Garrett MC, Albert EJ, Kellner CP, Mocco J, Connolly ES.
    Neurosurgery; 2007 Aug 01; 61(2):255-60; discussion 260-1. PubMed ID: 17762737
    [Abstract] [Full Text] [Related]

  • 19. Complement activation in patients with primary antiphospholipid syndrome.
    Oku K, Atsumi T, Bohgaki M, Amengual O, Kataoka H, Horita T, Yasuda S, Koike T.
    Ann Rheum Dis; 2009 Jun 01; 68(6):1030-5. PubMed ID: 18625630
    [Abstract] [Full Text] [Related]

  • 20. [Immunological tests: Anaphylatoxins C3a, C4a, C5a].
    Fujino S, Sakurabayashi I.
    Nihon Rinsho; 2005 Jul 01; 63 Suppl 7():80-3. PubMed ID: 16111194
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.